Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information

Websiteinsphero.com
Twitter@insphero
CategoryBioTech
Phone+41-44-515049-0
Employees
Founded2009

Offices

Zurich, CHE
Technoparkstrasse 1
Zurich, 8005, CHE

People

Funding

TOTAL $3.84M
FUNDING TOTAL $3.84M
Series A, 8/2010
Redalpine Venture Partners
ZKB Start-up Finance
$1.74M
Series B, 6/2013
$2.1M

Tags

InSphero

InSphero AG develops organotypic biological 3D microtissues and microtissue-based assays for biochemical compounds screening and predictive drug testing applications. It offers human prostate and mammary carcinoma, and rat liver microtissues. The company also provides compound toxicity testing, cell-invasion assays, stem-cell research, cell-to-cell interaction, regenerative medicine, tissue engineering, and cell-to-extracellular matrix interaction services. In addition, it involves in study of transcriptomics, proteomics, and metabolomics. Further, the company provides custom development services, which include microtissue development, H and E stained paraffin sections, growth characteristics data, and morphometric data. Its microtissue system enables the generation of various model systems using either tumor-derived cells to reconstitute primary tumors, or primary cells to mimick structure and function of diverse organ tissues. InSphero AG was founded in 2009 and is based in Zurich, Switzerland.

Recent Milestones

Videos

Screenshots

Sources

  1. release: 3D microtissue manufacturer InSphero secures Series A financing (insphero.com) [edit]
  2. InSphero Raises CHF 2 Mln in Series B Financing (pehub.com) [edit]
Edit This Page
Last Edited 4/10/14

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize ยป

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy